BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37561721)

  • 1. Efficacy of novel SARS-CoV-2 rapid antigen tests in the era of omicron outbreak.
    Widyasari K; Kim S
    PLoS One; 2023; 18(8):e0289990. PubMed ID: 37561721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated antigen assays display a high heterogeneity for the detection of SARS-CoV-2 variants of concern, including several Omicron sublineages.
    Osterman A; Krenn F; Iglhaut M; Badell I; Lehner A; Späth PM; Stern M; Both H; Bender S; Muenchhoff M; Graf A; Krebs S; Blum H; Grimmer T; Durner J; Czibere L; Dächert C; Grzimek-Koschewa N; Protzer U; Kaderali L; Baldauf HM; Keppler OT
    Med Microbiol Immunol; 2023 Oct; 212(5):307-322. PubMed ID: 37561226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable detection of Omicron-BA.1 and -BA.2 by SARS-CoV-2 rapid antigen tests.
    Osterman A; Badell I; Dächert C; Schneider N; Kaufmann AY; Öztan GN; Huber M; Späth PM; Stern M; Autenrieth H; Muenchhoff M; Graf A; Krebs S; Blum H; Czibere L; Durner J; Kaderali L; Baldauf HM; Keppler OT
    Med Microbiol Immunol; 2023 Feb; 212(1):13-23. PubMed ID: 36370197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten rapid antigen tests for SARS-CoV-2 widely differ in their ability to detect Omicron-BA.4 and -BA.5.
    Krenn F; Dächert C; Badell I; Lupoli G; Öztan GN; Feng T; Schneider N; Huber M; Both H; Späth PM; Muenchhoff M; Graf A; Krebs S; Blum H; Durner J; Czibere L; Kaderali L; Keppler OT; Baldauf HM; Osterman A
    Med Microbiol Immunol; 2023 Oct; 212(5):323-337. PubMed ID: 37561225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Clinical Performance of InteliSwab
    Fischl MJ; Young J; Kardos K; Roehler M; Miller T; Wooten M; Holmes N; Gula N; Baglivo M; Steen J; Zelenz N; Joyee AG; Munster V; Weishampel Z; Yinda CK; Rouse KG; Gvozden C; Wever D; Yanez G; Anderson M; Yu S; Bearie B; Young S; Berry JD
    Viruses; 2023 Dec; 16(1):. PubMed ID: 38257761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of multiplex allele-specific RT-qPCR assays for differentiation of SARS-CoV-2 Omicron subvariants.
    Li J; Cheng R; Bian Z; Niu J; Xia J; Mao G; Liu H; Wu C; Hao C
    Appl Microbiol Biotechnol; 2024 Dec; 108(1):35. PubMed ID: 38183475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of rapid antigen tests in identifying Omicron BA.4 and BA.5 infections in South Africa.
    Samsunder N; Lustig G; de Vos M; Ngcapu S; Giandhari J; Tshiabuila D; San EJ; Lewis L; Kharsany AB; Cawood C; de Oliveira T; Abdool Karim Q; Abdool Karim S; Escadafal C; Naidoo K; Sivro A
    J Clin Virol; 2023 Aug; 165():105498. PubMed ID: 37329842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical performance of the rapid qualitative antigen kit for the detection of SARS-CoV-2 during widespread circulation of the Omicron variant.
    Suzuki H; Akashi Y; Kato D; Takeuchi Y; Kiyasu Y; Terada N; Kurihara Y; Kuwahara M; Muramatsu S; Ueda A; Notake S; Nakamura K
    J Infect Chemother; 2023 Mar; 29(3):257-262. PubMed ID: 36417995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of COVID-19 symptoms with omicron subvariants BA.2 and BA.5, host status, and clinical outcomes in Japan: a registry-based observational study.
    Nakakubo S; Kishida N; Okuda K; Kamada K; Iwama M; Suzuki M; Yokota I; Ito YM; Nasuhara Y; Boucher RC; Konno S
    Lancet Infect Dis; 2023 Nov; 23(11):1244-1256. PubMed ID: 37399831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of SARS-CoV-2 Omicron on Rapid Antigen Testing Developed for Early-Pandemic SARS-CoV-2 Variants.
    Leuzinger K; Roloff T; Egli A; Hirsch HH
    Microbiol Spectr; 2022 Aug; 10(4):e0200622. PubMed ID: 35943268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Detection Tests Using Oral, Anterior Nasal, and Nasopharyngeal Swabs: a Diagnostic Accuracy Study.
    Wölfl-Duchek M; Bergmann F; Jorda A; Weber M; Müller M; Seitz T; Zoufaly A; Strassl R; Zeitlinger M; Herkner H; Schnidar H; Anderle K; Derhaschnig U
    Microbiol Spectr; 2022 Feb; 10(1):e0202921. PubMed ID: 35107327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of rapid antigen tests for Omicron subvariants of SARS-CoV-2.
    Sakai-Tagawa Y; Yamayoshi S; Halfmann PJ; Wilson N; Bobholz M; Vuyk WC; Wei W; Ries H; O'Connor DH; Friedrich TC; Sordillo EM; van Bakel H; Simon V; Kawaoka Y
    J Med Virol; 2023 May; 95(5):e28788. PubMed ID: 37212288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid Identification of SARS-CoV-2 Omicron BA.5 Spike Mutation F486V in Clinical Specimens Using a High-Resolution Melting-Based Assay.
    Aoki A; Adachi H; Mori Y; Ito M; Sato K; Kinoshita M; Kuriki M; Okuda K; Sakakibara T; Okamoto Y; Jinno H
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus variant-specific clinical performance of a SARS-CoV-2 rapid antigen test with focus on Omicron variants of concern.
    Bornemann L; Kaup O; Kleideiter J; Ruprecht B; Hoyer A; Panning M; Bornemann R; Wehmeier M
    Clin Microbiol Infect; 2023 Aug; 29(8):1085.e1-1085.e8. PubMed ID: 37182639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of the Omicron SARS-CoV-2 Lineage and Its BA.1 Variant with Multiplex RT-qPCR.
    Yolshin ND; Komissarov AB; Varchenko KV; Musaeva TD; Fadeev AV; Lioznov DA
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique mutations in SARS-CoV-2 Omicron subvariants' non-spike proteins: Potential impacts on viral pathogenesis and host immune evasion.
    Hossain A; Akter S; Rashid AA; Khair S; Alam ASMRU
    Microb Pathog; 2022 Sep; 170():105699. PubMed ID: 35944840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico evaluation of the impact of Omicron variant of concern sublineage BA.4 and BA.5 on the sensitivity of RT-qPCR assays for SARS-CoV-2 detection using whole genome sequencing.
    Sharma D; Notarte KI; Fernandez RA; Lippi G; Gromiha MM; Henry BM
    J Med Virol; 2023 Jan; 95(1):e28241. PubMed ID: 36263448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of rapid antigen tests (RAT) for COVID-19 and factors associated with RAT-negative results among RT-PCR-positive individuals during Omicron BA.2, BA.5 and XBB.1 predominance.
    Tan CY; Zeng K; Cui L; Lin RTP; Chen M
    BMC Infect Dis; 2024 May; 24(1):504. PubMed ID: 38769524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Clinical Outcomes and Imaging Features in Hospitalized Patients with SARS-CoV-2 Omicron Subvariants.
    Lee JE; Hwang M; Kim YH; Chung MJ; Jeong WG; Sim BH; Jeong YJ
    Radiology; 2023 Jul; 308(1):e230653. PubMed ID: 37462497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Omicron subvariants exhibit distinct fusogenicity, but similar sensitivity, to pan-CoV fusion inhibitors.
    Xia S; Wang L; Jiao F; Yu X; Xu W; Huang Z; Li X; Wang Q; Zhu Y; Man Q; Jiang S; Lu L
    Emerg Microbes Infect; 2023 Dec; 12(1):2178241. PubMed ID: 36748716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.